S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
Billionaires Are Now FLOODING Into Gold (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Billionaires Are Now FLOODING Into Gold (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
Billionaires Are Now FLOODING Into Gold (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Billionaires Are Now FLOODING Into Gold (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
Billionaires Are Now FLOODING Into Gold (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Billionaires Are Now FLOODING Into Gold (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
Billionaires Are Now FLOODING Into Gold (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Billionaires Are Now FLOODING Into Gold (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case

ImmunoPrecise Antibodies (IPA) SEC Filings & 10K Form

$1.90
+0.18 (+10.47%)
(As of 02/23/2024 ET)

Recent ImmunoPrecise Antibodies SEC Filings

DateFilerForm TypeView
02/23/2024
4:26 PM
ImmunoPrecise Antibodies (Filer)
Form 424B5
02/23/2024
4:29 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
2:12 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K/A
01/10/2024
12:53 PM
Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
Form SC 13G/A
01/10/2024
12:33 PM
Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
Form SC 13G
12/14/2023
7:48 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
7:38 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
7:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/08/2023
4:11 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
3:53 PM
ImmunoPrecise Antibodies (Filer)
Form 424B5
12/06/2023
4:19 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2023
6:57 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2023
5:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2023
7:31 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2023
4:13 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2023
7:50 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2023
7:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2023
7:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2023
1:56 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2023
10:56 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2023
3:46 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2023
7:02 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2023
1:47 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2023
7:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2023
7:02 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2023
7:30 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
7:14 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2023
3:38 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K/A
08/09/2023
8:15 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2023
11:15 PM
ImmunoPrecise Antibodies (Filer)
Form EFFECT
07/14/2023
7:10 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
3:32 PM
ImmunoPrecise Antibodies (Filer)
Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d)
07/07/2023
2:22 PM
ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13D
07/07/2023
7:36 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2023
8:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2023
6:41 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2023
7:09 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
7:04 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2023
10:35 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2023
9:01 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2023
11:53 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2023
7:04 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2023
8:05 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/23/2023
7:19 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2023
7:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2023
7:08 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2023
7:04 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2023
7:52 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IPA) was last updated on 2/25/2024 by MarketBeat.com Staff